Clinical Trials
Found 12 recent publications
New Experimental Weight-Loss Drug Retatrutide Sparks Medical Safety Warnings
A groundbreaking weight-loss drug, Retatrutide, offers high efficacy in clinical trials but triggers severe medical warnings regarding gray-market counterfeits.
Weight-Loss Drugmakers Pivot Focus From Total Pounds Lost to Preserving Muscle
Weight-loss drug developers are shifting focus from total weight reduction to preserving muscle mass, as clinical trials from Novo Nordisk, Eli Lilly, and Regeneron target healthier body composition outcomes.
Kodiak Sciences Stock Surges 200% on Positive Phase 3 Trial Results
American biomedical firm Kodiak Sciences saw its stock surge nearly 200% on Nasdaq after reporting positive Phase 3 clinical trial results for its retinal disease treatments.
Viking Therapeutics Shares Surge 35% on Positive Obesity Drug Trial Results
Viking Therapeutics shares surged 35% on Wall Street after reporting positive trial results for its obesity and diabetes drug VK2735, showing significant weight loss.
US FDA Launches Pilot Program to Accelerate Drug Development and Clinical Trials
The US FDA has launched the Expedited IND Pilot program to accelerate clinical trial approvals, shortening the lengthy preparation process for new drug developments.
The Science of Longevity: Challenges and Breakthroughs in Heart Disease Treatment
A new weekly column explores the science of longevity and recent setbacks in cardiovascular research, including clinical trials targeting Lipoprotein(a) and inflammation.
FDA Approves Mitochondrial Therapy for Bill Ackman's Daughter; Novo Nordisk Rebrands
The FDA approves innovative mitochondrial therapy for Bill Ackman's daughter, Novo Nordisk rebrands to Novo, Pfizer enforces vaccine debt, and RedDress advances wound care.
Medical Milestone: Israeli Spinal Cord Development Cleared for Human Trials
A dramatic breakthrough in the rehabilitation of the paralyzed: The US Food and Drug Administration (FDA) has approved the design of the first human clinical trial for Matriself. Here are the details on the revolutionary technology poised to transform medical treatment.
Out of 66 side effects attributed to statins, only 4 are proven to be caused by the drugs
A massive study examining dozens of side effects attributed to popular cholesterol-lowering drugs has found that only four are actually caused by the treatment.
Breakthrough in pancreatic cancer: The drug that doubled survival
Significant news in the fight against one of the deadliest cancers: a new oral drug has nearly doubled the median survival of patients with metastatic pancreatic cancer who had already received prior treatment, compared to standard chemotherapy. The drug, Daraxonrasib (RMC-6236), was tested in a phase 3 study called RASolute 302, showing a median overall survival of 13.2 months versus 6.7 months...
A Revolution in Drug Development: Israeli Startup Raises $45 Million
Developing a new drug is one of the most time-consuming and expensive processes in medicine. Despite billions in investment, many drugs fail during clinical trials. The Israeli startup QuantHealth has secured $45 million to expand its artificial intelligence platform, which aims to optimize the planning and execution of clinical trials.
The startup QuantHealth raised $45 million for AI technology for clinical trial planning
QuantHealth, a company developing AI-based simulations for clinical trials, has raised $45 million in a Series B funding round. The total amount raised by the company has now reached $75 million.